通过收集医生意见和通过Sermo的全球社交平台提供有针对性的内容,Movember为前列腺癌患者提供额外支持
纽约,纽约,2021年9月28日/ B3C newswire / - True North,金宝搏官网mga global prostate cancer website created by Movember , the leading charity focused on men's health, has partnered with Sermo to provide physicians with enhanced resources for their prostate cancer patients. The partnership offers doctors and other HCPs on the Sermo platform access to True North’s educational content and tools pertaining to men’s health and prostate cancer.
Sermo will collect data and insights from their ...
VIENNA, Austria, September 28, 2021 / B3C newswire / -- Delta 4 , a digital drug discovery company focusing on the identification of new indications for existing drug compounds, today announced that Dr. Hans Lehrach will join its Scientific Advisory Board. Prof. Lehrach is a distinguished scientist in the area of genomics.
„We are excited to have Dr. Lehrach join our Scientific Advisory Board“, commented Kurt Herpel, CEO, Delta 4. Herpel added: „His insights and his direction as an eminent expert in genetics and personalized medicine will be a boost for Delta 4 as we are accelerating the application of our ...
BERLIN, Germany, September 28, 2021 / B3C newswire / -- ProBioGen today announced the closing of a DirectedLuck Transposase Technology research license agreement with another global biopharma company. The license covers the evaluation of the DirectedLuck Transposase technology in their cell line development processes.
DirectedLuck builds on a transposase's principle but with additional major improvements. It has been optimized to recognize specific chromatin marks, guiding the transgene to genomic regions with highest transcriptional activity, which ensures exceptionally high protein expression and maximum stability. The clone pools generated within days to weeks are highly representative of later clones. ...
FRANKLIN LAKES, N.J., September 22, 2021 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, completed a preliminary study investigating the impact of deep cold storage (-20°C and -40°C) on glass PFS.
While traditional vaccine formulations are commonly stored up to about 2°C-8°C, new vaccine formulations – including those for mRNA – require much colder storage for ...
RAVENSBURG, Germany, September 21, 2021 / B3C newswire /—— The " Vetter added this topic to its corporate agenda many years ago. Now, the pharmaceutical service provider is making ...
PFÄFFIKON, Switzerland, September 21, 2021 / B3C newswire / -- Pureos Bioventures , a venture capital fund dedicated to support private biotech companies developing novel therapies, announced the appointment of several venture partners to its team. The first-time fund has USD 205 million under management and has invested in 11 private biotech companies so far. In addition, Pureos is a partner at BaseLaunch, an incubator of biotech startups in Basel, Switzerland. First portfolio companies of Pureos Bioventures have already gone public or have been acquired.
As new venture partners Dr. Dragan Grabulovski, Ian Metcalfe and Dr. Roberto Iacone have joined the ...
HAMBURG, Germany, September 20, 2021 / B3C newswire / -- Cellbox Solutions GmbH , developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market.
Following the successful development and production of the Cellbox transportable CO2 incubator in 2019, as well as suitable UN3373 packaging materials for cell transport, the young company has decided to expand into the USA. The high amount of enquiries from the US market made it obvious to take the next step and expand to the USA. The market was previously served by a distribution partner, but effective ...
In Sermo’s most recent COVID-19 Real Time Barometer survey , most physicians reported that they have not seen long-COVID or long-haul cases among children, however, a substantial 26% did say they have ...
BERLIN, Germany, August 24, 2021 / B3C newswire / -- Pharmacokinetic and immunogenicity projects can be both diverse and complex, involving work packages from antibody generation and production to the analysis of clinical samples with validated assays. At the end of June, an agreement was signed by BioGenes GmbH and ...
Opening a new facility, Biotage triples its production capacity for equipment crucial in the supply chain for the production of mRNA vaccines.
UPPSALA, Sweden, August 16, 2021 / B3C newswire / -- Biotage is one of the few companies offering a complete solution and ready to go off-the-shelf products for the purification of large-scale lipids, used in mRNA vaccine development and production. Expanding its production capacity of large-scale flash columns by 300 per cent, Biotage is now helping pharmaceutical companies and contract manufacturers’ scale up lipid production for COVID-19 vaccines. A new, bespoke production facility is now operational at ...
HEIDELBERG and HAMBURG, Germany, August 10, 2021 / B3C newswire / -- VERAXA Biotech GmbH , Heidelberg, and Indivumed GmbH , Hamburg, announced today their agreement to jointly discover modulatory and functional antibodies against several targets that are relevant for colorectal cancer. The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development and commercialization will be performed by Indivumed’s subsidiary, Ix Therapeutics.
VERAXA Biotech GmbH is a pioneer in microfluidic technology for the screening of antibodies with modulatory function on complex signal proteins like GPCRs ...
VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX™System2021 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec, today announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants.
VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX™ can be used as a combined test ...